Find clinical trials for Diabetes in Louisville, KY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus

Type 2 Diabetes Mellitus

Type 1 Diabetes Mellitus

Diabetic Foot

Obesity

Foot Ulcer

Ulcer

Diabetes trials near Louisville, KY, USA:

A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...

Active, not recruiting

Recent Onset type1 Diabetes

Drug: Placebo

Drug: Ladarixin

Phase 2

Dompé

Louisville, Kentucky, United States and 56 other locations

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting

Diabetes Mellitus, Type 2

Drug: Semaglutide

Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk

Louisville, Kentucky, United States and 180 other locations

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes (PIONEER TEENS)

This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested t...

Active, not recruiting

Diabetes Mellitus, Type 2

Drug: Oral semaglutide

Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk

Louisville, Kentucky, United States and 65 other locations

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Part...

Enrolling

Type 2 Diabetes

Drug: Dulaglutide

Phase 3

Lilly

Louisville, Kentucky, United States and 28 other locations

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight (SYNCHRONIZE™-2)

index of 27 kg/m² or more. People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exer...

Active, not recruiting

Diabetes Mellitus, Type 2

Obesity

Drug: Survodutide

Drug: Placebo

Phase 3

Boehringer Ingelheim

Louisville, Kentucky, United States and 145 other locations

Status recently updated

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help reduce the symptoms associated with diabetic...

Enrolling

Active, not recruiting

Diabetic Gastroparesis

Drug: Placebo

Drug: CIN-102 Dose 15mg or 10mg

Phase 2

CinDome Pharma

Louisville, Kentucky, United States and 100 other locations

Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

at Week 52 in participants with overweight or obesity without diabetes mellitus (Cohort A) and in participants with overweight or obesity wi...

Active, not recruiting

Type 2 Diabetes Mellitus

Overweight

Drug: Placebo

Biological: Maridebart Cafraglutide

Phase 2

Amgen

Louisville, Kentucky, United States and 78 other locations

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes (ONWARDS 11)

The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly co...

Begins enrollment this month

Diabetes Mellitus, Type 1

Drug: Insulin glargine

Drug: Insulin icodec

Phase 3

Novo Nordisk

Louisville, Kentucky, United States and 169 other locations

Fenofibrate for Prevention of DR Worsening (Protocol AF)

fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...

Enrolling

Diabetic Retinopathy

Other: Placebo

Drug: Fenofibrate

Phase 3

Jaeb Center for Health Research

New Albany, Indiana, United States and 62 other locations

A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk (ACHIEVE-4)

The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes...

Active, not recruiting

Type 2 Diabetes

Chronic Kidney Disease

Drug: Orforglipron

Drug: Insulin Glargine

Phase 3

Lilly

Louisville, Kentucky, United States and 370 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Diabetes in .css-epvm6{white-space:nowrap;}Louisville, KY

Related conditions:

Diabetes trials near Louisville, KY, USA:

A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes (PIONEER TEENS)

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight (SYNCHRONIZE™-2)

A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis

Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes (ONWARDS 11)

Fenofibrate for Prevention of DR Worsening (Protocol AF)

A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk (ACHIEVE-4)

Find clinical trials for Diabetes in Louisville, KY